Animal disease models play a crucial role in biomedical research, providing essential insights into the pathophysiology of diseases and the mechanisms of therapeutic interventions. These models are indispensable in the evaluation of drug efficacy, safety, and pharmacokinetics, bridging the gap between in vitro studies and human clinical trials. By accurately replicating human disease conditions, animal models enable researchers to observe the effects of potential treatments in a controlled environment, ensuring that only the most promising therapies advance to the next stage of development.

At HBI, other than surgically induced models, we offer a broad spectrum of in vivo disease models designed to advance your preclinical research such as Chemically-induced models, Genetically-induced models, Spontaneous models and Tumor models (e.g., xenograft).

Our services encompass the development and utilization of highly relevant and validated animal models that replicate human disease conditions, including oncology, cardiovascular diseases, neurodegenerative disorders, metabolic diseases, immune-related conditions and infectious diseases.

With a strong focus on scientific accuracy and reproducibility, our team employs cutting-edge techniques to induce, monitor, and assess disease progression and therapeutic response. We provide comprehensive study designs tailored to meet your specific research objectives, utilizing advanced imaging, biomarker analysis, and physiological monitoring to deliver robust and insightful data.

Our commitment to excellence is underscored by our adherence to GLP standards and our dedication to ethical animal research practices.

Partnering with HBI ensures that your in vivo disease model studies are conducted with the highest levels of scientific integrity and operational efficiency, driving your research forward towards clinical application and therapeutic innovation.